ALN-BCAT

· Alnylam Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-BCAT, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma [Phase 1]